Stem Cell Development & Manufacturing | Q&As & Interviews

In Conversation with Stephen Sullivan, COO of iPSirius

Cell & Gene 2024 Conference Producer Anya Chuykov met with Stephen Sullivan, COO of iPSirius, to discuss the advancements being made by iPSirius, and their unique proprietary technology working to treat aggressive forms of cancer.

Stephen shares insights into trends and challenges in the CGT space, and looks to Cell & Gene 2024 this November as an opportunity to connect with and address challenges with fellow key opinion leaders. Join the event to hear Stephen present on the Innovation & Collaboration track and discuss emerging modalities within the advanced therapy landscape on our C- & Executive level panel.